EVH logo

Evolent Health (EVH) EBITDA

annual EBITDA:

$80.06M+$104.84M(+423.00%)
December 31, 2024

Summary

  • As of today (June 2, 2025), EVH annual EBITDA is $80.06 million, with the most recent change of +$104.84 million (+423.00%) on December 31, 2024.
  • During the last 3 years, EVH annual EBITDA has risen by +$24.39 million (+43.83%).
  • EVH annual EBITDA is now -77.16% below its all-time high of $350.45 million, reached on December 31, 2015.

Performance

EVH EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEVHincome statement metrics

quarterly EBITDA:

-$28.70M-$40.80M(-337.37%)
March 31, 2025

Summary

  • As of today (June 2, 2025), EVH quarterly EBITDA is -$28.70 million, with the most recent change of -$40.80 million (-337.37%) on March 31, 2025.
  • Over the past year, EVH quarterly EBITDA has dropped by -$47.49 million (-252.81%).
  • EVH quarterly EBITDA is now -107.65% below its all-time high of $375.20 million, reached on December 31, 2015.

Performance

EVH quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEVHincome statement metrics

TTM EBITDA:

$32.57M-$47.49M(-59.32%)
March 31, 2025

Summary

  • As of today (June 2, 2025), EVH TTM EBITDA is $32.57 million, with the most recent change of -$47.49 million (-59.32%) on March 31, 2025.
  • Over the past year, EVH TTM EBITDA has dropped by -$7.43 million (-18.59%).
  • EVH TTM EBITDA is now -90.71% below its all-time high of $350.45 million, reached on December 31, 2015.

Performance

EVH TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEVHincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

EVH EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+423.0%-252.8%-18.6%
3 y3 years+43.8%-317.5%-43.8%
5 y5 years+131.4%+48.6%+111.7%

EVH EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+423.0%-177.1%+37.6%-59.3%+181.1%
5 y5-yearat high+131.4%-177.1%+84.4%-59.3%+107.1%
alltimeall time-77.2%+131.4%-107.7%+85.9%-90.7%+107.1%

EVH EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$28.70M(-337.4%)
$32.57M(-59.3%)
Dec 2024
$80.06M(-423.0%)
$12.09M(+1.2%)
$80.06M(+29.7%)
Sep 2024
-
$11.96M(-67.9%)
$61.74M(-6.4%)
Jun 2024
-
$37.22M(+98.2%)
$65.92M(+64.8%)
Mar 2024
-
$18.79M(-401.7%)
$40.00M(-261.4%)
Dec 2023
-$24.79M(-219.8%)
-$6.23M(-138.6%)
-$24.79M(+862.5%)
Sep 2023
-
$16.14M(+42.9%)
-$2.58M(-93.6%)
Jun 2023
-
$11.30M(-124.6%)
-$40.16M(+4.3%)
Mar 2023
-
-$46.00M(-387.8%)
-$38.51M(-286.1%)
Dec 2022
$20.69M(-62.8%)
$15.98M(-174.5%)
$20.69M(-28.2%)
Sep 2022
-
-$21.44M(-265.6%)
$28.83M(-50.9%)
Jun 2022
-
$12.95M(-1.9%)
$58.69M(+1.3%)
Mar 2022
-
$13.20M(-45.3%)
$57.91M(+3.8%)
Dec 2021
$55.66M(-123.1%)
$24.12M(+186.5%)
$55.82M(+24.0%)
Sep 2021
-
$8.42M(-30.8%)
$45.03M(+103.0%)
Jun 2021
-
$12.17M(+9.6%)
$22.19M(-112.8%)
Mar 2021
-
$11.11M(-16.7%)
-$173.84M(-27.8%)
Dec 2020
-$240.74M(-5.4%)
$13.33M(-192.4%)
-$240.74M(-47.5%)
Sep 2020
-
-$14.42M(-92.2%)
-$458.13M(+1.5%)
Jun 2020
-
-$183.85M(+229.5%)
-$451.26M(+61.7%)
Mar 2020
-
-$55.80M(-72.7%)
-$279.00M(+9.6%)
Dec 2019
-$254.52M
-$204.06M(+2603.2%)
-$254.52M(+404.7%)
Sep 2019
-
-$7.55M(-34.9%)
-$50.43M(+14.4%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$11.59M(-63.0%)
-$44.09M(+38.9%)
Mar 2019
-
-$31.32M(<-9900.0%)
-$31.76M(+664.8%)
Dec 2018
-$4.15M(-89.7%)
$27.00K(-102.2%)
-$4.15M(-60.9%)
Sep 2018
-
-$1.22M(-262.2%)
-$10.61M(-32.2%)
Jun 2018
-
$749.00K(-120.2%)
-$15.64M(-45.9%)
Mar 2018
-
-$3.71M(-42.3%)
-$28.94M(-28.4%)
Dec 2017
-$40.40M(-81.6%)
-$6.43M(+3.0%)
-$40.40M(-34.4%)
Sep 2017
-
-$6.25M(-50.2%)
-$61.56M(-8.9%)
Jun 2017
-
-$12.55M(-17.3%)
-$67.60M(+5.9%)
Mar 2017
-
-$15.18M(-45.0%)
-$63.81M(-71.0%)
Dec 2016
-$220.06M(-162.8%)
-$27.59M(+124.6%)
-$220.06M(-220.4%)
Sep 2016
-
-$12.29M(+40.3%)
$182.73M(+1.1%)
Jun 2016
-
-$8.76M(-94.9%)
$180.82M(+1.0%)
Mar 2016
-
-$171.43M(-145.7%)
$179.03M(-48.9%)
Dec 2015
$350.45M(>+9900.0%)
$375.20M(-2744.1%)
$350.45M(-1516.3%)
Sep 2015
-
-$14.19M(+34.4%)
-$24.75M(+134.4%)
Jun 2015
-
-$10.55M(<-9900.0%)
-$10.55M(<-9900.0%)
Mar 2015
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2014
$0.00(-100.0%)
$0.00(0.0%)
-$10.99M(0.0%)
Sep 2014
-
$0.00(0.0%)
-$10.99M(0.0%)
Jun 2014
-
$0.00(-100.0%)
-$10.99M(0.0%)
Mar 2014
-
-$10.99M
-$10.99M
Dec 2013
-$19.95M
-
-

FAQ

  • What is Evolent Health annual EBITDA?
  • What is the all time high annual EBITDA for Evolent Health?
  • What is Evolent Health annual EBITDA year-on-year change?
  • What is Evolent Health quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Evolent Health?
  • What is Evolent Health quarterly EBITDA year-on-year change?
  • What is Evolent Health TTM EBITDA?
  • What is the all time high TTM EBITDA for Evolent Health?
  • What is Evolent Health TTM EBITDA year-on-year change?

What is Evolent Health annual EBITDA?

The current annual EBITDA of EVH is $80.06M

What is the all time high annual EBITDA for Evolent Health?

Evolent Health all-time high annual EBITDA is $350.45M

What is Evolent Health annual EBITDA year-on-year change?

Over the past year, EVH annual EBITDA has changed by +$104.84M (+423.00%)

What is Evolent Health quarterly EBITDA?

The current quarterly EBITDA of EVH is -$28.70M

What is the all time high quarterly EBITDA for Evolent Health?

Evolent Health all-time high quarterly EBITDA is $375.20M

What is Evolent Health quarterly EBITDA year-on-year change?

Over the past year, EVH quarterly EBITDA has changed by -$47.49M (-252.81%)

What is Evolent Health TTM EBITDA?

The current TTM EBITDA of EVH is $32.57M

What is the all time high TTM EBITDA for Evolent Health?

Evolent Health all-time high TTM EBITDA is $350.45M

What is Evolent Health TTM EBITDA year-on-year change?

Over the past year, EVH TTM EBITDA has changed by -$7.43M (-18.59%)
On this page